KKR, a prominent global investment firm, along with Impilo, a Nordic healthcare investment firm, has agreed to acquire Immedica Pharma, a Swedish-based pharmaceutical company specializing in rare diseases and specialty care products. As part of the deal, Impilo will reinvest…
ImmunityBio, Inc. (NASDAQ: IBRX), a leader in immunotherapy, has just received FDA approval for ANKTIVA (N-803, or nogapendekin alfa inbakicept-pmln) in combination with Bacillus Calmette-Guérin (BCG). This approval marks a significant advancement in the treatment of patients with BCG-unresponsive non-muscle…
Hyperfine, Inc. (Nasdaq: HYPR), known for its groundbreaking health technology, has initiated the CARE PMR observational study, enrolling the first patients. The study aims to evaluate the clinical utility and workflow benefits of its FDA-cleared portable magnetic resonance (MR) brain…
Cera, the acclaimed digital home healthcare provider, has appointed four new members to its Advisory Board: Lord Wood of Anfield, Hilary Evans, Benjamin Wegg-Prosser, and Samantha Jones. Cera, the esteemed digital home healthcare provider, has augmented its Advisory Board with…
ResearchAndMarkets.com now offers the “Global Infectious Disease In vitro Diagnostics Market (2024 Edition)” report. This comprehensive analysis covers various aspects including technology (such as Immunoassay, Molecular Diagnostics, Microbiology, and Other Technologies), product type, end user, region, and country, providing valuable…
CharmHealth, a prominent provider of healthcare technology solutions, has officially launched its 2024 Innovation Challenge. This annual event aims to uncover fresh concepts that can revolutionize healthcare and its associated systems and procedures. The Innovation Challenge offers a platform for…
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical firm dedicated to pioneering treatments for neurological disorders and cardio-renal disease, has disclosed the dosing of the first patient in its relaunched Phase 2/3 ReMEDy2 Trial of DM199 for acute ischemic stroke…
Saghmos Therapeutics, Inc. (Saghmos), a privately owned biopharmaceutical firm, has disclosed its collaboration with the Duke Clinical Research Institute (DCRI) to enhance and strategize the implementation of Saghmos’ Phase 3 study for its cardio-renal metabolic modulator ST-62516. Saghmos Therapeutics, Inc.…
Butterfly Network, Inc. (“Butterfly”), a pioneering digital health company focused on revolutionizing healthcare with portable, semiconductor-based ultrasound technology and user-friendly software, has announced a collaborative effort involving three key players: the Clinton Health Access Initiative (CHAI), a globally recognized health…
Identiv, Inc. (NASDAQ: INVE), a worldwide leader in digital security and identification within the Internet of Things (IoT) realm, has welcomed Kirsten Newquist to its team. With nearly three decades of experience in building thriving businesses, Ms. Newquist joins as…
Fullscript, a prominent figure in healthcare platforms designed for comprehensive care, has revealed its plans to organize a virtual Cardiometabolic Summit on April 17-18th, 2024. This summit aims to bring together a diverse audience comprising both conventional and functional clinicians.…
Exciting Partnership: Alula Technologies Joins Forces with ROOK, a Pioneer in Wearable Health Data Platform Alula, renowned for its AI-driven technology solutions enhancing customer experiences and risk understanding, partners with ROOK, a trailblazer in wearable health data platforms. Alula’s expertise…